{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=isoniazid&page=2", "query": { "intervention": "isoniazid", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=isoniazid&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-24T20:34:07.674Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02410772", "title": "TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tuberculosis" ], "interventions": [ { "name": "rifapentine", "type": "DRUG" }, { "name": "rifapentine and moxifloxacin", "type": "DRUG" }, { "name": "control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 2516, "start_date": "2016-01-25", "completion_date": "2021-05", "has_results": true, "last_update_posted_date": "2024-12-04", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 5, "location_summary": "San Francisco, California • New York, New York • Fort Worth, Texas + 2 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Fort Worth", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02410772" }, { "nct_id": "NCT04272242", "title": "Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infection", "LTBI" ], "interventions": [ { "name": "Dolutegravir (DTG)", "type": "DRUG" }, { "name": "Isoniazid (INH)", "type": "DRUG" }, { "name": "Rifapentine (RPT)", "type": "DRUG" }, { "name": "Antiretroviral Therapy (ART)", "type": "DRUG" }, { "name": "Pyridoxine (Vitamin B6)", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 37, "start_date": "2021-02-27", "completion_date": "2021-12-27", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 2, "location_summary": "San Francisco, California • Houston, Texas", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04272242" }, { "nct_id": "NCT05411744", "title": "One-month Latent Tuberculosis Treatment for Renal Transplant Candidates", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Latent Tuberculosis", "End Stage Renal Disease", "Renal Transplant Candidate for Right Kidney", "Renal Transplant Candidate for Left Kidney" ], "interventions": [ { "name": "1 month Rifapentine, Isoniazid and Vitamin B6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 25, "start_date": "2022-07-01", "completion_date": "2029-06-30", "has_results": false, "last_update_posted_date": "2026-01-21", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05411744" }, { "nct_id": "NCT00201123", "title": "Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tuberculosis", "AIDS-related Complex" ], "interventions": [ { "name": "Aerosol Interferon-Gamma", "type": "DRUG" }, { "name": "Subcutaneous interferon-gamma", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 89, "start_date": "2005-04", "completion_date": "2007-08", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00201123" }, { "nct_id": "NCT00023335", "title": "TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Tuberculosis" ], "interventions": [ { "name": "Rifapentine", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "1995-04", "completion_date": "2001-03", "has_results": false, "last_update_posted_date": "2005-09-05", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Los Angeles, California • San Francisco, California + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00023335" }, { "nct_id": "NCT02563327", "title": "Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tuberculosis" ], "interventions": [ { "name": "Rifapentine", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" }, { "name": "Pyrazinamide", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" }, { "name": "Pyridoxine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2516, "start_date": "2016-01-25", "completion_date": "2021-08-30", "has_results": true, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02563327" }, { "nct_id": "NCT02641106", "title": "VDOT for Monitoring Adherence to LTBI Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tuberculosis", "Latent Tuberculosis Infection" ], "interventions": [ { "name": "Video Directly Observed Therapy", "type": "OTHER" }, { "name": "In-Person DOT", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 129, "start_date": "2016-03-08", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2021-02-05", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02641106" }, { "nct_id": "NCT00164450", "title": "TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tuberculosis" ], "interventions": [ { "name": "Isoniazid", "type": "DRUG" }, { "name": "Rifapentine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 158, "start_date": "2005-09", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Los Angeles, California • San Diego, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00164450" }, { "nct_id": "NCT00164463", "title": "TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tuberculosis" ], "interventions": [ { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2004-07", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2011-06-08", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 6, "location_summary": "Los Angeles, California • Baltimore, Maryland • Durham, North Carolina + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Fort Worth", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00164463" }, { "nct_id": "NCT00140309", "title": "TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tuberculosis, Pulmonary" ], "interventions": [ { "name": "moxifloxacin (with isoniazid, rifampin, pyrazinamide)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 350, "start_date": "2003-07", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2007-03-19", "last_synced_at": "2026-09-24T20:34:07.674Z", "location_count": 18, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 13 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00140309" } ] }